FDA declines to approve nasal spray alternative to EpiPen
In a surprise to its makers, a nasal spray intended to be an alternative to the EpiPen was sent back by the FDA, the company announced.
Stay updated with breaking news from Asthma Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In a surprise to its makers, a nasal spray intended to be an alternative to the EpiPen was sent back by the FDA, the company announced.
After an FDA advisory committee said the decongestant phenylephrine, an ingredient found in many oral cold and flu medications, is ineffective, experts weigh in on alternatives.
When indoor air is too dry, you might experience unpleasant side effects like dry eyes and a scratchy throat. Here are the best humidifiers to help you breathe more comfortably.
The real cost of severe asthma: Why urgent action is needed to protect patients and reduce the strain on stretched health systems.
/PRNewswire/ -- Allergy & Asthma Network today announced the appointment of Lynda Mitchell, MA, CAE, as its new Chief Executive Officer. The nationwide...